BOULDER, Colo., Sept. 20 /PRNewswire-FirstCall/ -- Pharmion Corporation today announced that Erle Mast, the Company's executive vice president and chief financial officer, will present a corporate overview at the UBS 2007 Global Life Sciences Conference in New York.
The presentation will take place at 11:00 a.m. (Eastern) on Thursday, September 27, 2007 at the Grand Hyatt Hotel in New York City.
There will be a live webcast of the presentation from the conference. The webcast will be available through a link posted on the investor relations section of the Pharmion website at http://investor.pharmion.com. The webcast will be available for replay on Pharmion's website until at least November 30, 2007. The presentation will also be available to download as a podcast.
About Pharmion
Pharmion is a biopharmaceutical company focused on acquiring, developing and commercializing innovative products for the treatment of hematology and oncology patients in the U.S., Europe and additional international markets. Pharmion has a number of products on the market including the world's first approved epigenetic drug, Vidaza(R), a DNA demethylating agent. For additional information about Pharmion, please visit the company's website at http://www.pharmion.com.
Pharmion CorporationCONTACT: Breanna Burkart or Anna Sussman, Directors, Investor Relationsand Corporate Communications of Pharmion Corporation, +1-720-564-9150
Web site: http://www.pharmion.com/
